Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database

Fig. 3

IC025 of SSIBs associated with GLP-1 RA in the sensitivity analysis. When IC025 >0, a disproportionate reporting signal was detected. FAERS, US Food and Drug Administration Adverse Event Reporting System; IC, information component; SSIBs, Suicidal and Self-Injurious Behaviors; GLP-1 RA, GLP-1 receptor agonist

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us